chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LEFT THE CLINIC AFTER 5 INJECTS THAT DAY HE WAS SCREAMIN INCONSOLIBLE,  GOT HOME WITH IN 2 HOURS HE STARTED HIS FEVER, IT CLIMBED TO 104 .3F I STARTED TRYING TO LOWER  IT IMMEDIATLY! LOWEST I COULD KEEP IT WAS 102. BUT STAYED TRYING AND DID CLIMB BACK UP OFF AND ON NEXT CAME THE NASTIEST I'VE EVER SEEN THEN THE RASH FROM HEAD TO TOE THAT WE WENT TO THE DOCTOR FOR YES I SHOULD HAVE WENT THE FIRST DAY I'LL ALWAYS BE SORRY!!!! ANYWAY SHE SAID IT FROM THE VACCINES SHOULD BE FINE YEA RIGHT THEN HE QUITE TALKING COMPLETELY, HE SIT IN A DAZE FOR HOURS AND NEVER MAKE A SOUND.  I TOOK HIM BACK TO DOCTOR AND I AM GETTING THE COMPLETE RUN AROUND IT I NEED TO KNOW IF HE IS OK  OR IF HIS BRAIN IS SWOLLEN AND INJURED ASAP
Patient was seen on 12/5/2020 and treated for cellulitis with Clindamycin 300mg - Take 1 capsule every 8 hours for 7 days. (symptoms, signs , time course and outcome unknown)
Arm is sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm is sore at the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm is sore at the injection site). At the time of the report, VACCINATION SITE PAIN (Arm is sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
temperature of 102F; A spontaneous report was received from a consumer concerning a female patient of unknown age,who received Modena's COVID-19 vaccine (mRNA-1273) and experienced fever. The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unknown date, the patient received their second of two planned doses of mRNA-1273 (lot/batch unknown)  for prophylaxis of COVID-19 infection.  On an unspecified date,the patient developed fever,temperature of 102 F. No laboratory data was provided.Treatment information was not provided.  Action taken with mRNA-1273 in response to the events  was unknown . The outcome of the event pyrexia was unknown at the time of the report
UNABLE TO GET UP FROM  BED OFTEN; PANCREATITIS; This spontaneous report received from a patient concerned a 55-year-old, white and not Hispanic or Latino female. The patient's past medical history included endometriosis, and covid-19, and concurrent conditions included non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies and no history of drug abuse or illicit drug use. The patient stated that she had Covid-19 in Aug-2020 and continued to have antibodies for 11 months. On 05-Jul-2021, the patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: JAN55ZUC.1S2050210, and expiry: Unknown) dose was not reported, 1 total, administered on right arm for prophylactic vaccination.  No concomitant medications were reported.  On 27-Jul-2021, Tuesday, the patient was diagnosed with pancreatitis and was hospitalized on 28-Jul-2021. The patient stated she had not received any medication during her time in the hospital and only received fluids.  The patient mentioned she received heparin because she was not able to get up from bed often. The patient was discharged on 1-Aug-2021. The patient was hospitalized for 4 days. On an unspecified date in Jul-2021, Laboratory data included: Antibody test (NR: not provided) not specified and patient stated that she maintains natural immunity.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from pancreatitis, and the outcome of unable to get up from bed often was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210802888-covid-19 vaccine ad26.cov2.s-Pancreatitis, unable to get up from bed often . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
15OCT slurred speech & weakness (recvd shot p/17OCT) & on 18OCT had weakness & wouldn't get out of bed; MD stated may have had a stroke in progress a/flu shot;  25OCT94 f/u speech clear, can use both arms-no paralysis;
A couple days after the second dose of the Pfizer vaccine, I began to notice that food I was eating tasted horrible. At first, I thought it was the food, but I soon realized there was something wrong with me. Food that I normally loved tasted so awful that I felt like puking whenever I tried to take a bite of it. I also noticed everything smelled terrible. I could eat almost nothing. Chocolate, cake, vegetables, rice, pasta, and more all tasted and smelled so awful to me. I could only eat some fruits and bread, and sometimes pizza.  This went on for 2 months before it started to improve. Slowly, my sense of taste and smell returned to normal, and it could about 2-3 more months for it to be completely normal.  After about 6 weeks of this, I sought treatment with a ENT doctor who apparently had experience with my condition. He checked me out and said I seemed fine otherwise. He recommended I retrain my smell and taste my smell and tasting strong spices. This may have helped me start to improve.
itchy red bump at the site of injection; itchy red bump at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy red bump at the site of injection) and VACCINATION SITE ERYTHEMA (itchy red bump at the site of injection) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchy red bump at the site of injection) and VACCINATION SITE ERYTHEMA (itchy red bump at the site of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE (topical) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (itchy red bump at the site of injection) and VACCINATION SITE ERYTHEMA (itchy red bump at the site of injection) had resolved.            Concomitant drug was not reported.  It was reported that event lasted for approximately 3 weeks.   This case was linked to MOD-2021-208304 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow-up information received on 03 JUN 2021 contains Updated Event outcome from unknown to resolved.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Rash/Itchy entire body presented to ER on 11/01/2003.  Flu shot given 10/29/2003.  Rash appeared 10/30/2003.  Given Solunadrol 125mg (IM).  Diplenhydratine and Prednisone.  Rash resolved 11/06/2003.
Received SHINGRIX vaccine 03/14/19. Pt experienced nausea, vomiting, diarrhea, hot flashes and congestion to the heart around 10 or 11 pm that night. As up to today (03/18/19) pt still has diarrhea.
He was complaining of his stomach hurting about a hr after the shot, he threw up twice before I took him to the ER - I even feed him but he still threw up and comp about a headache and back ache.
symptoms reappeared after day 6, and tested positive; symptoms reappeared after day 6, and tested positive; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 78-year-old male patient received BNT162b2 (BNT162B2), on 12Apr2022 at 11:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 77 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "Gout" (unspecified if ongoing); "Known allergies: PCN" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Known allergies: bactrim for Known allergies: Bactrim. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "symptoms reappeared after day 6, and tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: Treatment of COVID-19; (10Jun2022) Negative, notes: Tested negative after 4 days of Paxlovid; (22Jun2022) Positive, notes: tested positive for the next 16 days; (23Jun2022) Negative, notes: Symptoms abating, and tested negative on day 17. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Anti viral details COVID 19 Treatment, treatment start date: 07Jun2022,stop date: 11Jun2022, indication: Treatment of COVID-19. Adverse event: Very bad taste. Tested negative after 4 days of Paxlovid. Improving. Then symptoms reappeared after day 6, and tested positive for the next 16 days. Symptoms abating, and tested negative on day 17. Also flare up of gout while on Paxlovid. Adverse event start date: 08Jun2022 and stop date: Jun2022. outcome: Recovered with lasting effects.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information available and close temporal association, a possible contributory role of the suspect Product cannot be excluded for the reported events . The case will be reassessed once new information is available.
Vomiting; Weakness; He had a small fever (99.4); Sleepy; Fatigue; This is a spontaneous report from a contactable consumer(Patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 2 via an unspecified route of administration on 06Apr2021 02:45 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (BNT162B2, Solution for injection, PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. On 06Apr2021 06:00 the patient experienced he had a small fever (99.4), sleepy, fatigue, vomiting, weakness. Patient reported also vomited like 5 times now. The patient underwent lab tests and procedures which included body temperature was 99.4 on 06Apr2021. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
1.  Very tired, fatique, no energy which has never subsided.  I sleep alot. 2. Headache sporadically, now daily. 3. Back pain near kidney developed a week after vaccine. 4.  Thirsty and for 3 days unquenchable thirst. 5.  Had spurts of joint pain all over for several days. Did not have these symptoms with 1st vaccine, this has been progressing for 2 weeks, as of tomorrow, and got worse as time passed. I am very active and healthy and this has certainly impacted my routine.  I still work. Visit to Dr. about back pain resulted in negative test and Dr. blamed it on vaccine.
fever, SOB around 3 am day after shot. Back pain, leg pain, pt was given Vicodin @ ER, did EKG
pt recvd MMR & fainted in waiting room approx 5-10 min later c/o headache immed a/fainting; was conscious approx 5-10secs w/in falling; BP 100/60, P63; had small egg size lump on lf occipt area fr fall to floor;
Same day post vax, the pt experienced swelling, redness, pruritus, and soreness in the vaccinated arm, extending down to the elbow. She was unable to raise her arm above her head. On the second day, she was unable to raise it above her shoulder.
On 4/6/00, the pt experienced a sore, swollen, red arm. Subsequently, the pt recovered.
Information has been received from a certified medical assistant referring to an unspecified number of patients of unknown age and gender. There was no medical history or drug reactions/allergies reported. Since January 2016 the patients were vaccinated with improperly stored doses of MMR II (lot # L026551 with expired date 16-JAN-2017, digital data logger, dose and route were unknown). No concomitant therapy was reported. The improperly stored vaccines were stored under 53.8 F for 4 hours and 48 minutes and there was no previous temperature excursion. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
Patient received an entire diluted vial of the Pfizer vaccine (6 doses). Nursing facility contacted the physician and patient was monitored. Local pain and swelling at the injection site was only adverse effect noted.
Swelling, redness, warm to touch. Treatment - cool compresses, Ibuprofen.
Developed terrible arrhythmia, atrial fibrillation, tachycardia days after 2nd dose and these symptoms did not go away and were made worse after receiving booster vaccine; Developed terrible arrhythmia, atrial fibrillation, tachycardia days after 2nd dose and these symptoms did not go away and were made worse after receiving booster vaccine; Developed terrible arrhythmia, atrial fibrillation, tachycardia days after 2nd dose and these symptoms did not go away and were made worse after receiving booster vaccine; Developed terrible arrhythmia, atrial fibrillation, tachycardia days after 2nd dose and these symptoms did not go away and were made worse after receiving booster vaccine; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient.  A 49-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 11Jan2022 (Batch/Lot number: unknown) at the age of 49-years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (Batch/Lot number: unknown, as dose 1, single), for COVID-19 immunisation and BNT162B2 (Batch/Lot number: unknown, as dose 2, single), for COVID-19 immunisation, reactions: "Terrible arrhythmia", "Atrial fibrillation", and "Tachycardia". The following information was reported: ARRHYTHMIA (medically significant), CONDITION AGGRAVATED (medically significant), ATRIAL FIBRILLATION (medically significant) and TACHYCARDIA (medically significant) all with onset 13Jan2022, outcome "not recovered" and all described as "Developed terrible arrhythmia, atrial fibrillation, tachycardia days after 2nd dose and these symptoms did not go away and were made worse after receiving booster vaccine." The event "Developed terrible arrhythmia, atrial fibrillation, tachycardia days after 2nd dose and these symptoms did not go away and were made worse after receiving booster vaccine" was evaluated at the physician office visit. Therapeutic measures were taken as a result of arrhythmia, condition aggravated, atrial fibrillation, and tachycardia and included treatment with metoprolol.  Clinical course: The patient had no prior cardiac issues. Prior to vaccination, she was not diagnosed with COVID-19 and since the vaccination, she has not been tested for COVID-19. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
ON TUESDAY - 9/12/17 SHE C/O MINOR POST FLU VACCINNATION REACTIONS - SORE ARM, MUSCLE ACHES, HEADACHE ; ON WEDNESDAY - 9/13/17 C/O MORE SEVERE REACTION = NAUSEA / DIZZINESS / HEAD SPINNING / TONGUE SWELLING -- > DENIED DIFFICULTY BREATHING IN THE THROAT OR SWALLOWING, BUT FELT TIGHTNESS IN THE CHEST WITH DEEP INSPIRATION.
felt whole body extremely hot right away/still feels warm; got very flushed; This spontaneous case was reported by a health care professional and describes the occurrence of FEELING HOT (felt whole body extremely hot right away/still feels warm) and FLUSHING (got very flushed) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced FEELING HOT (felt whole body extremely hot right away/still feels warm) and FLUSHING (got very flushed). At the time of the report, FEELING HOT (felt whole body extremely hot right away/still feels warm) and FLUSHING (got very flushed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. Treatment included ice pack, water and the patient was laid down.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Nov2021 at 08:30 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 52 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Sulfa drugs" (unspecified if ongoing), notes: Known allergies: Sulfa drugs (as child). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive. Therapeutic measures were taken as a result of covid-19, which included Paklovid, regular 5 day treatment, from 10May2022 to 14May2022. Headache and nausea - Day 3 felt almost normal but then on Day 4 of Treatment felt general malaise with bad headache and slight nausea and stayed in bed resting, could not concentrate. Although did not impact appetite as was still hungry and ate 3 meals a day. Note my dosing sch was noon and midnight-started noon 5-10. Still feel off on Day 5.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Death Narrative: Patient had Parkinson's and advanced Dementia. He was on a palliative care unit and a DNR.
my head and neck turned bright red; My tongue, lips, and inside of my mouth were tingling and became numb; My tongue, lips, and inside of my mouth were tingling and became numb; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER 2613), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient stated after waiting at the facility for 15 minutes after the vaccination, about 10 minutes later, my head and neck turned bright red and heated up like it was on fire on my drive home. My tongue, lips, and inside of my mouth were tingling and became numb. I pulled off the road and sat for another 10 minutes in my car. The symptoms began to subside. The outcome of the event was recovering.  No follow-up attempts are needed. No further information is expected.
I am a 63-year-old woman, who was in good health with no preexisting conditions.  I took the first injection Moderna COVID19 vaccine shot on Friday. September 24, 2021 due to the mandate to keep my job as a substitute teacher.  I started feeling bad and my breathing deteriorated each day to the point where I was out of breath.  On Wednesday, September 29, 2021, I went to urgent care.   After initial check-up, they called the ambulance and I was transported to the Emergency Room and immediately placed on high flow oxygen.  One more day delay and I would have died due to lack of oxygen. At the hospital, on Thursday, September 30, 2021, the doctor removed ONE Liter (Quart) of fluid from my right lung, the next day the doctor removed ONE and ONE THIRD liters of fluid from my left lung.  The fluid was a rusty reddish color.   At the hospital, all kinds to tests were performed, heart test, cancer test, COVID19 test and bacterial tests, all results were negative.  By Saturday, I was off oxygen and was released from the hospital on Monday, October 4, 2021.  By the end of the week, I again started feeling out of breath.  On Monday, October 11, the doctor ordered a chest X-ray.  The x-ray was read on Tuesday morning.  The Doctor immediately called me and told me to go to Emergency Room at Medical Center.  On Wednesday, October 13, 2021, surgery was performed on me to install draining tubes from both of my lungs.  More than a liter of fluid was removed from each of my lungs.  Again, more tests were performed on me to find the root cause and none were found.  On Friday, October 15, I was released from the hospital with tubes from my lungs.    On Sunday, October 17, 2021, the visiting nurse came to my house and drained 25 ml from my right lung and 75 ml from my left lung. The nurse is scheduled to come three times a week to remove the fluid. I am currently suffering from swelling in my feet, myocarditis and pericarditis and unable to work in this condition, as a result of the Moderna vaccine.
This spontaneous report as received from a registered nurse refers to a 3 months old patient of unknown gender. The patient's concurrent conditions, medical history and drug allergies were not reported. On 04-NOV-2016, the patient was vaccinated with improperly stored PEDVAXHIB (dose and route not reported) from lot # M025194, expiry date: 22-MAR-2019 for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous temperature excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1610USA014705: US-009507513-1610USA014706: US-009507513-1610USA008140.
NUMBNESS ON THE INJECTION SITE (RIGHT ARM) AND WENT ON THE BACK OF MY SHOULDER, THEN TINGLING FEELING FROM HIP TO FOOT AROUND 6PM ON THE DAY OF VACCINATION. THE NEXT DAY, NUMBNESS ON THE SHOULDER WENT AWAY BUT THE TINGLING FEELING FROM HIP TO FOOT IS PERSISTENT UP TO TODAY ESPECIALLY WHEN STANDING.